QuickView for W2 domain (biogroup)

1. L1000 CMAP - Umbilical vein endothelial HUVEC cells treated with small molecule perturbagens
2. L1000 CMAP - T-cell ALL JURKAT cells treated with small molecule perturbagens
3. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
4. Uteri of ovariectomized mice with ESR1 mutations treated with estradiol
5. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)

There were no matches for W2 domain

1. Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
2. TEOSYAL® RHA Ultra Deep and Perlane-L® for the Correction of Nasolabial Folds
3. TEOSYAL® RHA Global Action, TEOSYAL® RHA Deep Lines, and Juvéderm® Ultra XC for the Correction of Na…
4. to Evaluate the Preliminary Efficacy and Safety of GR1501 Injection in Patients With Active Axial Sp…
5. Eye Movements Desensitization and Reprocessing Intervention in Preventing Craving in Alcohol Use Dis…